Our rationale is that, if prevention of HK2 dissociation from mitochondria is directly responsible for the attenuation of changes to mitochondria function at the end of ischemia, then its removal from IPC end-ischemic mitochondria should change these parameters back to those of non-preconditioned end-ischemic mitochondria. The gene discussed is HK2; the disease is ischemia.